UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?
Schwalen F, Ghadi C, Ibazizene L, Khan SU, Sopkova-de Oliveira Santos J, Weiswald LB, Voisin-Chiret AS, Meryet-Figuiere M, Kieffer C.
Schwalen F, et al. Among authors: khan su.
J Med Chem. 2025 Jan 13. doi: 10.1021/acs.jmedchem.4c01517. Online ahead of print.
J Med Chem. 2025.
PMID: 39806871
Review.